An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms

Clinical trial NCT01726270 · COMPLETED

Trial details

NCT number: NCT01726270
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lower Urinary Tract Symptoms

Start date: 2012-11-01
Primary completion: 2013-03-01
Enrollment: 689

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.